iBio, Inc. — Director's Dealing 2012

Dec 11, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2012-12-01

Reporting Person: Corcoran Andrea (Senior VP, Finance & Strategy)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.72	2022-12-01	Common Stock (100000)		Direct

Footnotes

F1: The option vests in three equal annual installments, beginning on the date of grant.